The bottom half of the list featured Reckitt Benckiser’s Mucinex, AstraZeneca’s Breztri Aerosphere, Otsuka’s Rexulti, ...

The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...

Topline Securities Ltd said the index was lifted by positive contributions from Oil and Gas Development Company Ltd, Pakistan ...

Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...

LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

The U.S. Food and Drug Administration has proposed removing oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it ...

Awareness among Younger Generation Higher about Benefits of Timely Sarcopenia Treatment InterventionRockville, MD, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The world population has crossed 8 billion, with a ...

Global sarcopenia treatment market was valued USD 3.07 billion in 2023, growing at a compound annual growth rate (CAGR) of 4.48% during the forecast period 2024-2032. Read the Market Summary Here @ ...

(Reuters) -Haleon posted an unexpected drop in third-quarter revenue on Thursday, hurt by a weak demand for its painkiller in ...

Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts.